SION - Sionna Therapeutics, Inc.
35.93
1.370 3.813%
Share volume: 310,437
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$34.56
1.37
0.04%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-12-2025 | 11-05-2025 | 03-02-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 19.659 M | 23.805 M | 23.612 M | |
| Selling general and admin | 5.991 M | 7.761 M | 8.444 M | |
| Research and development | 13.668 M | 16.044 M | 15.168 M | |
| Total expenses | 19.659 M | 23.805 M | 23.612 M | |
| 21.09% | -0.81% | |||
| Operating income | -19.659 M | -23.805 M | -23.612 M | |
| Ebit | -19.482 M | -23.734 M | -23.612 M | |
| Pretax income | -16.482 M | -20.278 M | -20.859 M | |
| 23.03% | 2.87% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -16.482 M | -20.278 M | -20.440 M | |
| -23.03% | -0.80% |